224 related articles for article (PubMed ID: 34889397)
1. Treatment of older adult or frail patients with multiple myeloma.
Grant SJ; Freeman CL; Rosko AE
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):46-54. PubMed ID: 34889397
[TBL] [Abstract][Full Text] [Related]
2. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
Grant SJ; Mian HS; Giri S; Boutin M; Dottorini L; Neuendorff NR; Krok-Schoen JL; Nikita N; Rosko AE; Wildes TM; Zweegman S
J Geriatr Oncol; 2021 May; 12(4):499-507. PubMed ID: 33342724
[TBL] [Abstract][Full Text] [Related]
3. Management of Newly Diagnosed Elderly Multiple Myeloma Patients.
Antoine-Pepeljugoski C; Braunstein MJ
Curr Oncol Rep; 2019 May; 21(7):64. PubMed ID: 31127403
[TBL] [Abstract][Full Text] [Related]
4. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?
Möller MD; Gengenbach L; Graziani G; Greil C; Wäsch R; Engelhardt M
Curr Opin Oncol; 2021 Nov; 33(6):648-657. PubMed ID: 34534141
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
Isaacs A; Fiala M; Tuchman S; Wildes TM
J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
[TBL] [Abstract][Full Text] [Related]
7. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.
Patel BG; Luo S; Wildes TM; Sanfilippo KM
JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review.
Mian H; Brouwers M; Kouroukis CT; Wildes TM
J Frailty Aging; 2019; 8(4):215-221. PubMed ID: 31637409
[TBL] [Abstract][Full Text] [Related]
9. High-risk multiple myeloma: how to treat at diagnosis and relapse?
Mateos MV; Martínez BP; González-Calle V
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):30-36. PubMed ID: 34889431
[TBL] [Abstract][Full Text] [Related]
10. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
11. Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
Mian H; Wildes TM; Vij R; Pianko MJ; Major A; Fiala MA
Blood Cancer J; 2023 May; 13(1):76. PubMed ID: 37164972
[TBL] [Abstract][Full Text] [Related]
12. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
Lee HS; Lee J; Jo JC; Jung SH; Lee JJ; Kim D; Lee S; Song K
Sci Rep; 2021 Nov; 11(1):22907. PubMed ID: 34824362
[TBL] [Abstract][Full Text] [Related]
13. Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.
Engelhardt M; Ihorst G; Duque-Afonso J; Wedding U; Spät-Schwalbe E; Goede V; Kolb G; Stauder R; Wäsch R
Haematologica; 2020 May; 105(5):1183-1188. PubMed ID: 32241848
[No Abstract] [Full Text] [Related]
14. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
J Geriatr Oncol; 2024 Mar; 15(2):101681. PubMed ID: 38104480
[TBL] [Abstract][Full Text] [Related]
15. Characterize, Optimize, and Harmonize: Caring for Older Adults With Hematologic Malignancies.
Wildes TM; Artz AS
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-9. PubMed ID: 33979197
[TBL] [Abstract][Full Text] [Related]
16. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma.
Mian HS; Wildes TM; Fiala MA
JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30547157
[TBL] [Abstract][Full Text] [Related]
17. Treatment Considerations for Transplant-Ineligible Multiple Myeloma.
Elnair R; Holstein S
Oncology (Williston Park); 2021 Apr; 35(4):170-182. PubMed ID: 33886251
[TBL] [Abstract][Full Text] [Related]
18. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
[TBL] [Abstract][Full Text] [Related]
19. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
Mian H; McCurdy A; Giri S; Grant S; Rochwerg B; Winks E; Rosko AE; Engelhardt M; Pawlyn C; Cook G; Jackson G; Bringhen S; Facon T; Larocca A; Zweegman S; Wildes TM
Blood Cancer J; 2023 Jan; 13(1):6. PubMed ID: 36599867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
